Observational studyNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register.

Emanuele D'Amico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.